Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000688786 | SCV000816410 | uncertain significance | Epileptic encephalopathy | 2023-07-07 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 568428). This variant has not been reported in the literature in individuals affected with RYR3-related conditions. This variant is present in population databases (rs780056230, gnomAD 0.04%). This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 665 of the RYR3 protein (p.Ile665Thr). |
Ambry Genetics | RCV004659167 | SCV005158875 | uncertain significance | not specified | 2024-06-22 | criteria provided, single submitter | clinical testing | The c.1994T>C (p.I665T) alteration is located in exon 18 (coding exon 18) of the RYR3 gene. This alteration results from a T to C substitution at nucleotide position 1994, causing the isoleucine (I) at amino acid position 665 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |